Tile Shop TTSH
September 30, 2021 - 3:20pm EST by
2021 2022
Price: 7.60 EPS 0 0
Shares Out. (in M): 52 P/E 0 0
Market Cap (in $M): 376 P/FCF 8.5 0
Net Debt (in $M): -40 EBIT 0 0
TEV (in $M): 336 TEV/EBIT 0 0

Sign up for free guest access to view investment idea with a 45 days delay.

  • Disclaimer is longer than writeup


Tile Shop is a compelling risk/reward at $7.5 per share or ~5.4x FY21E Adj. EBITDA of $60MM and a mid- teens FCF yield ex-cash. We believe a combination of technical tailwinds over the coming months along with operational execution, a strong R&R environment and capital allocation will allow TTSH to rerate to ~$12 per share. If not, we believe TTSH would make an excellent acquisition/platform candidate for a sponsor.
Business Overview
Tile Shop is a specialty retailer of floor and wall tiles, with 143 stores and 5 DCs covering a majority of the US. It is estimated as the third largest independent flooring/tile retailer. For the LTM period TTSH generated $351MM of rev and ~$52MM of Adj. EBITDA.
Why Does This Opportunity Exist?
Complicated corporate history ranging from an accurate short report on inventory/related party issues to a delisting that ended up in litigation, former CEO/founder throwing mgmt. under the bus in a public letter, etc.
o The delisting/pink sheets headwind has been resolved as well as indiscriminate selling
from the founder.
ERP roll-out issues which have since been alleviated.
Recent selling for the ousted former CEO has been an overhang on the stock.
Catalyst to Re-rate & Investment Highlights
Technical catalysts include sell-side coverage, eligibility into the fundamental small cap long only
crowd and R2000 inclusion in FY22. This should lead to 20%+ of float acquired by passive
In response to COVID, TTSH reduced store hours, particularly for Sundays. With TTSH selectively
reopening stores on Sundays, we should see incremental volumes from the corresponding comp
uplift. We believe an MSD sales comp is sustainable over the coming two years.
o In conjunction with operating leverage, incremental EBITDA margins should be in excess
30% leading to strong flow-through.
o TTSH can increase their store footprint within existing markets as well as potential evergreen opportunities now that the balance sheet and other issues are resolved. Once the market sees positive comps and positive unit growth, the multiple will likely expand.
TTSH utilized COVID to right size their cost structure, reducing low-end sales performers. This increased the commission pool for its better employees, aligning incentives
TTSH has excess capital with a Fort Knox balance sheet of ~$40MM and ought to generate well over $30MM of FCF for FY21E. We’d expect some type of return of capital either buybacks or dividends.
TTSH screens well on a fundamental basis with earnings/EBITDA growth and FCF inflecting positive for algos.
Per the shareholder litigation/depositions in 2020, it was revealed by the board that their intent was to sell ultimately clean up and sell the company. With the company appearing to be mostly cleaned up, we think TTSH could be an attractive platform candidate for a sponsor. HOME/MIK sold for ~9x+ EBITDA multiples, while SIC sold off its assets in excess of 10x EBITDA. We think TTSH would fetch $11 to $14 in a sale.
Key Risk
Cycle turns negative for repair and remodel or other potential housing headwinds. Thus far, results and commentary for the go forward have been positive. Moreover, cost structure is now more in line vs the past issues.
Supply chain issues have plagued multiple issues. We believe they have a good handle on their inventory plus we think companies in general are more prone to getting a pass for supply chain mishaps this upcoming Q (particularly after the BBBY/MU/NKE blow ups)


Author may buy or sell additional shares or all of these shares at any time. Author has no obligation to inform anyone of any changes to Author’s view of TTSH or any ticker noted above. The information set forth in this article does not constitute a recommendation to buy or sell any security. This article represents the opinion of the author as of the date of this article. Please consult your financial, legal, and/or tax advisors before making any investment decisions. This article contains certain "forward-looking statements," which may be identified by the use of such words as "believe," "expect," "anticipate," "should," "planned," "estimated," "potential," "outlook," "forecast," "plan" and other similar terms. While the Author has tried to present facts it believes are accurate, the Author makes no representation as to the accuracy or completeness of any information contained in this note. 

To the best of our ability and belief, all information contained herein is accurate and reliable, and has been obtained from public sources we believe to be accurate and reliable, and who are not insiders or connected persons of the stock covered herein or who may otherwise owe any fiduciary duty or duty of confidentiality to the issuer. We have a good-faith belief in everything we write; however, all such information is presented "as is," without warranty of any kind – whether express or implied.

In no event will we be liable for any direct or indirect trading losses caused by any information available on this report. Think critically about our opinions and do your own research and analysis before making any investment decisions. By downloading, reading or otherwise using this report, you agree to do your own research and due diligence before making any investment decision with respect to securities discussed herein, and by doing so, you represent to us that you have sufficient investment sophistication to critically assess the information, analysis and opinions in this report. You should seek the advice of a security professional regarding your stock transactions.

This document or any information herein should not be interpreted as an offer, a solicitation of an offer, invitation, marketing of services or products, advertisement, inducement, or representation of any kind, nor as investment advice or a recommendation to buy or sell any investment products. The reader agrees not to invest based on this note, and to perform his or her own due diligence and research before taking a position in TTSH or any tickers noted above. READER AGREES TO HOLD AUTHOR HARMLESS AND HEREBY WAIVES ANY CAUSES OF ACTION AGAINST AUTHOR RELATED TO THE NOTE ABOVE.

I do not hold a position with the issuer such as employment, directorship, or consultancy.
I and/or others I advise do not hold a material investment in the issuer's securities.


See the write up

    show   sort by    
      Back to top